Sign up to save your podcasts
Or
Share Rapid Whole-Genome Sequencing as a First-Line Test Is Likely to Significantly Reduce the Cost of Acute Care in a Private Payer System
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Rapid Whole-Genome Sequencing as a First-Line Test Is Likely to Significantly Reduce the Cost of Acute Care in a Private Payer System
View all episodes
By Association for Diagnostics and Laboratory Medicine
5
44 ratings
More shows like JALM Talk Podcast
View all
NEJM This Week
315 Listeners
Clinical Chemistry Podcast
25 Listeners
FT News Briefing
676 Listeners
JIMD Podcasts
9 Listeners